Thermo Fisher Scientific Inc. TMO
Set alert
At close · Oct 30
After hours · Oct 30, 7:00 PM ET
- YTD
- +20.29%
- 1 year
- +25.31%
- Open
- 710.69
- Prev close
- 709.18
- Mkt cap
- 257.71B
- Vol
- 2.09M
- Avg vol
- 2.09M
- EPS
- 18.96
- P/E
- 36.76
- Div yield
- 0.27%
More statistics
- Low
- 691.74
- High
- 711.79
- Forward P/E
- 25.11
- Beta
- 0.88
- Short ratio
- 1.98
- Inst. own
- 93.55%
- Dividend
- 1.88
- Ex-div date
- Sep 14, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 653.26
- 200-d avg
- 550.99
- 1y target
- 752.12
5D chart
Events in this range
- Oct 30, 2026Rating: Argus Research · Buy → Buy
Signals (140)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:40 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:30 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:25 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:00 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:55 PM | 1 day ago |
| RSI: Oversold | Oct 30, 2:40 PM | 1 day ago |
| RSI: Oversold | Oct 30, 2:15 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 1:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:50 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:45 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:55 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:20 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:10 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 12:10 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 12:00 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 11:55 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:20 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:15 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:00 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:55 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:50 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:50 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:40 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:35 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:05 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:30 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:15 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:05 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:20 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 10:10 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:05 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 2 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:00 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| RSI: Oversold | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:45 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:25 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:20 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:45 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 11:05 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:55 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:50 AM | 5 days ago |
News
22 hours ago benzinga.com
Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses proprietary data and pattern recognition to highlight five stocks just under the surface that deserve attention.
22 hours ago benzinga.com
Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet
The Stock Whisper Index is a market indicator highlighting stocks that are attracting heightened interest from traders and investors over the last trading week.
-
1 day ago benzinga.com
Argus Research Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $780
Argus Research analyst David Toung maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $560 to $780.
5 days ago seekingalpha.com
Parnassus Value Equity Fund Q3 2026 Portfolio Review
Parnassus Value Equity Fund (Investor Shares) returned -1.38% (net of fees) for the quarter, underperforming the Russell 1000 Value Index's 2.61%. Top contributors include Thermo Fisher, CME Group,…
5 days ago gurufocus.com
Is TMO Overvalued? DCF Says Worth $352
On October 26, 2026, we conducted a DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently trading at $673.82. The stock has shown a year-to-d
6 days ago seekingalpha.com
Baron Health Care Fund Q3 2026 Top Contributors And Detractors
TMO's organic growth of 5% exceeded consensus by 200 basis points, and management raised full-year organic growth guidance/. MTD's local-currency sales grew 6%, exceeding prior guidance of 3%. TEVA…
-
1 week ago benzinga.com
Citigroup Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $800
Citigroup analyst Patrick Donnelly maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $685 to $800.
1 week ago benzinga.com
Long-Awaited Qiagen Buyout Closes At 15x EBITDA Multiple as Slow Growth Curbs Pricing
Qiagen agrees to a $12 billion all-cash buyout by EQT. Analysts view the valuation discount as warranted given slower growth.
-
1 week ago benzinga.com
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $775
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $750 to $775.
-
1 week ago benzinga.com
RBC Capital Maintains Sector Perform on Thermo Fisher Scientific, Raises Price Target to $730
RBC Capital analyst Dan Leonard maintains Thermo Fisher Scientific (NYSE:TMO) with a Sector Perform and raises the price target from $580 to $730.
-
1 week ago benzinga.com
TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $810
TD Cowen analyst Dan Brennan maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $760 to $810.
1 week ago benzinga.com
Tesla To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for Tesla, Thermo Fisher, SentinelOne, Meta and Philip Morris; cut targets for Pegasystems, AT&T and Oklo.
-
1 week ago benzinga.com
Stifel Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $775
Stifel analyst Daniel Arias maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $650 to $775.
-
1 week ago benzinga.com
Baird Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $756
Baird analyst Catherine Schulte maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price target from $723 to $756.
1 week ago benzinga.com
Nasdaq Surges Over 1% As SpaceX Shares Gain: Investor Sentiment Improves, But Greed Index Remains In ‘Fear’ Zone
Market sentiment improved but stayed in Fear; U.S. stocks rose, led by tech, industrials and financials, while mortgage applications fell 5.3%.
1 week ago benzinga.com
Thermo Fisher Scientific Highlights Continued Strong Customer Activity
Thermo Fisher Scientific tops Q3 Street estimates and raises full-year 2026 earnings and revenue guidance.
1 week ago benzinga.com
Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings
U.S. stocks rose Wednesday, led by Nasdaq (+1.06%) and tech. Thermo Fisher beat estimates and raised guidance; oil fell, gold edged higher.
1 week ago benzinga.com
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
-
1 week ago benzinga.com
Thermo Fisher Scientific Raises FY2026 Adj EPS Guidance from $24.93-$25.33 to $25.13-$25.43 vs $25.14 Est; Raises FY2026 Sales Guidance from $47.400B-$48.100B to $47.700B-$48.200B vs $47.885B Est
Thermo Fisher Scientific (NYSE:TMO) raises FY2026 Adj EPS guidance from $24.93-$25.33 to $25.13-$25.43 vs $25.14 analyst estimate. Raises FY2026 sales outlook from $47.400 billion-$48.100 billion to…
1 week ago benzinga.com
Thermo Fisher Scientific Q3 2026 Earnings Call Transcript
Thermo Fisher Scientific (NYSE:TMO) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
1 week ago benzinga.com
Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings
Discover 9 stocks to watch ahead of Wednesday’s earnings, including Meta, Tesla and Lam Research, with options-implied moves reaching 7.42%.
1 week ago benzinga.com
9 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 week ago benzinga.com
Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings
Thermo Fisher reports Q3 earnings Oct. 21, with analysts expecting $6.40 EPS and $11.93B revenue; analysts remain bullish, raising price targets.
2 weeks ago benzinga.com
Lam Research Could Swing $28.6 Billion After Earnings
Discover 9 stocks with the biggest options-implied earnings moves, led by Spotify at 9.31%, as investors prepare for key quarterly results.
2 weeks ago benzinga.com
Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’
CNBC Final Trades: Weiss picked 10-year Treasuries, Thomas chose XAR, Firestone favored TMO, and Terranova selected PFE.
2 weeks ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
2 weeks ago benzinga.com
Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $730
Morgan Stanley analyst Tejas Savant maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $650 to $730.
-
2 weeks ago benzinga.com
TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760
TD Cowen analyst Dan Brennan maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $675 to $760.
-
3 weeks ago benzinga.com
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $650 to $750.
3 weeks ago benzinga.com
The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited
The S&P 500 hit a record high Tuesday, but only 15 of its 504 stocks did too. The median member trades 25% below its own peak.
3 weeks ago benzinga.com
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial
Quantum BioPharma signed an agreement with Thermo Fisher to initiate a Phase 2 clinical trial for its multiple sclerosis therapy, Lucid-MS.
3 weeks ago benzinga.com
JPMorgan’s October Stock Picks Hint at 3 ETF Trades: Value, AI Power, Health Care
JPMorgan’s October stock picks spotlight American Express, Liberty Energy and Thermo Fisher, opening ETF plays across value, AI power and health care.
3 weeks ago benzinga.com
Here’s How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.97% on an annualized basis producing an average annual return of 15.7%. Currently, Thermo Fisher Scientific…
1 month ago benzinga.com
Top 3 Health Care Stocks That May Keep You Up At Night This Month
Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused investors of potential near-term weakness.
1 month ago benzinga.com
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.
1 month ago benzinga.com
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’
CNBC’s final trades: INFL, Wells Fargo, Nutrien and Thermo Fisher. Wells Fargo beat Q2 estimates; Nutrien missed earnings but topped sales.
2 months ago benzinga.com
Elon Musk Says mRNA Has ‘Tremendous’ Potential After Moderna, Merck Cancer Vaccine Breakthrough — MRNA Stock Falls Over 11% in Premarket (UPDATED)
Elon Musk said mRNA could fundamentally change disease treatment, turning medicine into a software problem.
3 months ago benzinga.com
Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
Dan Loeb reduced his Danaher stake and exited Thermo Fisher in Q1 2026 as the billionaire investor trimmed life sciences exposure.
3 months ago benzinga.com
Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today
Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.
3 months ago benzinga.com
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday
U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd…
3 months ago benzinga.com
Earnings Scheduled For July 23, 2026
Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is…
3 months ago benzinga.com
Intel Could Swing $61.4 Billion in Value After Earnings This Week
Earnings season takes center stage next week with options markets pricing in big post-results moves. Benzinga selected top stocks to watch.
3 months ago benzinga.com
9 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
4 months ago benzinga.com
Arcturus Picks Thermo Fisher To Support Cystic Fibrosis Therapy
Arcturus partners with Thermo Fisher to support Phase 3 development and potential commercialization of ARCT-032 for cystic fibrosis.
-
4 months ago benzinga.com
Arcturus Therapeutics Collaborates With Thermo Fisher Scientific To Help Support Phase 3 Development And Potential Commercialization Of ARCT-032, Investigational mRNA Therapy For Cystic Fibrosis
Strategic manufacturing agreement includes Phase 3 clinical supply and commercial manufacturing rightsArcturus Therapeutics Holdings Inc. (("Arcturus", NASDAQ:ARCT), a messenger RNA medicines company…
4 months ago benzinga.com
This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Top Wall Street analysts change outlook on top names. See analyst ratings page for changes, including upgrades/downgrades/initiations.
5 months ago benzinga.com
Dan Loeb Dumps Microsoft, Slashes Nvidia And Rail Stocks In Sweeping Q1 Portfolio Overhaul
Daniel Loeb's Third Point added Meta, Alphabet, Broadcom, and semiconductor names while sharply cutting Nvidia and Microsoft positions in Q1.
5 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
5 months ago benzinga.com
Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge
Apple, Amazon and TSMC are among the largest companies to deliver earnings "triple plays" this season.
6 months ago benzinga.com
Phillips 66 To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga analysts changed outlook on top names. For all rating changes, incl upgrades/downgrades, see analyst ratings page. See other analysts' views.